Skip to main content
Search
User account menu
IRBManager
CTSU
Main navigation
Home
About
Our Mission
Our History
Who’s Involved
About the Boards
Adult CIRB - Late Phase Emphasis Members
Adult CIRB - Early Phase
Pediatric CIRB
Cancer Prevention and Control CIRB
CIRB SOPs
List of Institutions
Studies
For New Users
Overview of the Study Review Process
Frequently Asked Questions about Navigating IRBManager
When To Use NCI CIRB, IRBManager, and CTSU Websites
For Institutions
IRBManager Basics
Overview of the Study Review Process
Becoming A Signatory Institution
Navigating The CIRB For NCI Division of Cancer Prevention (DCP) Consortia Sites And Cancer Prevention Clinical Trial Network (CP-CTNET) Organizations
Create and Update the Signatory Institution Worksheet
Completing The Annual Signatory Institution Worksheet
Establishing Your Signatory Institution
Short Form Q & A
Creating and Updating the Annual Principal Investigator Worksheet
Establishing a Principal Investigator
How to Open a Study
Opening a Study
Change the PI on a Study
Changing the PI on a Study
Submit a Study Closure
Report A Potential Unanticipated Problem Or A Serious Or Continuing Noncompliance
Request an Assent Waiver
Completing The Assent Waiver Worksheet
Notify the CIRB about the participation of an incarcerated participant
Completing The Notification of Incarcerated Participant Worksheet
Institution Q & A
Boilerplate Language Q & A
Finding Information Q & A
Guidelines For Permitted Boilerplate Language Additions
Individual Roles Within The CIRB
Institutions' Roles With The CIRB
Managing Your CTEP Registration
Oversight Q & A
Updating Your CIRB Institution Roster using RUMS
Updating Your CIRB Person Roster using RUMS
Viewing Your CIRB Roster
For Networks
Overview of the Study Review Process
CIRB Document Posting
Submitting Studies
Completing The Translation Application
Completing The Unanticipated Problem And/Or Serious or Continuing Noncompliance Submission Application
Completing The Waiver Of Consent Application
Determining Waiver Of Consent Requirements
End User Licensing Agreement (Eula) Consent Form Language Q & A
Review of Translated Consent Forms, PROs, and Other Patient-Facing Documents
Submitting Recruitment/participant Materials For Review
CIRB Meeting Schedules
For Board Members
Become A Board Member
Overview of the Study Review Process
Resources
Helpful URLs
IRBManager Training for Board Members
CIRB Meeting Schedules
Contact Us
Additional Guidance Regarding Reporting of Minor Deviations for Clinical Trials Supported by the NCI DCP Phase 0-2 Cancer Prevention Clinical Trials Program
Memo_Additional_Guidance_Minor_Deviation_Reporting_Consortia_Studies_ COVID-19 Outbreak_3-27-20.docx
Close